APYX News and Press, Apyx Medical Corporation From 06/01/21

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

Apyx Medical Corporation (APYX) Q1 2021 Earnings Conference Call May 12, 2021, 8:00 am ET Company Participants Charlie Goodwin - President & CEO Tara Semb - CFO Conference Call Participants Dave Turkaly - JMP Securities Matt Hewitt - Craig-Hallum Korinne Wolfmeyer - Piper Sandler Russell ...

Advanced Energy Sales increased 92% year-over-year in Q1 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic ...

InMode is a leader in the medical aesthetic devices industry and blows competitors out of the water when comparing financial metrics. The company still possesses many traits of a multi-bagger, such as having high revenue growth, stable margins, and high returns on capital. Our upd...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

Apyx Medical Corporation (APYX) Q4 2020 Results Conference Call March 31, 2021 8:00 AM ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Ky...

Apyx Medical (APYX): Q4 GAAP EPS of -$0.04 beats by $0.12.Revenue of $11.5M (+37.2% Y/Y) beats by $1.23M.FY2021 guidance: Total revenue in the range of $36.7M- 38.7M, representing growth of 32% to 40% Y/Y, compared to $27.7M for the year ended December 31, 2020 vs. consensus of $39.65M.A...

Advanced Energy Sales increased 44% year-over-year in Q4 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic ...

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today a...

Gainers: [[DPW]] +46.3%. [[PFSW]] +39.9%. [[APYX]] +26.7%. [[MAXR]] +7.9%. [[SPCE]] +7.4%.Losers: [[SMLP]] -10.3%. [[VIRC]] -9.5%. [[VOLT]] -7.6%. [[TOUR]] -5.4%. [[HA]] -4.9%. For further details see: DPW, PFSW, APYX and VOLT among after-hours movers